Project CBD

OCTOBER 26, 2023

United Kingdom-based GW Pharmaceuticals has produced the world’s first approved cannabis-based medicines for the UK, US, and European markets, Sativex® and Epidiolex®. As part of the approval process for all markets, they have conducted critical Phase 2 studies on various conditions, including cancer.

Research and Development 347

Research and Development Cannabinoids Terpenes Pharmaceutical 347

Cannabis Law Report

AUGUST 10, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, today reported that its subsidiary Oravax Medical Inc. About MyMD Pharmaceuticals, Inc.

Clinical Trials 105

Clinical Trials Pharmaceutical Research and Development CBD 105

United Patients Group

MARCH 15, 2023

It can help patients manage pain, anxiety and other symptoms that may accompany chronic conditions such as fibromyalgia or PTSD. How it effects one patient, might effect someone with the same condition in a different way. The post Can Cannabis Help Patients Titrate Off Other Pharmaceutical Drugs?

Pharmaceutical 98

Pharmaceutical Patients Chronic Pain Sleep 98

Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because cannabis is still a schedule 1 drug in the U.S.,

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Leaf Science

DECEMBER 28, 2018

study shows that more and more people are giving up alcohol and pharmaceuticals in favour of cannabis use. are moving away from alcohol and pharmaceuticals in favour of cannabis use. The post New data shows Cannabis replacing Alcohol and Pharmaceuticals in the U.S. Consumer Profiles. Legalization.

Pharmaceutical 84

Pharmaceutical Data Recreational Topical 84

Veriheal

AUGUST 12, 2021

Unlike “pharmaceutical CBD”—which contains zero traces of the psychoactive compound THC (tetrahydrocannabinol) and has been FDA-approved to treat Dravet syndrome and Lennox-Gastaut syndrome —artisanal CBD is non-mechanized and usually contains variable amounts of CBD and THC. It goes by the name of “artisanal CBD.” .

Epilepsy 81

Epilepsy Pharmaceutical Patients Sleep 81

Cannabis Law Report

JUNE 7, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. About MyMD Pharmaceuticals, Inc. MyMD is a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms.

Pharmaceutical 79

Pharmaceutical Clinical Trials CBD Banking 79

FloridaMarijuana.net

JUNE 22, 2018

Patients who suffer from this condition also face other symptoms that are painful, inconvenient -to say the least, -and lower their quality of life. Many of these medications have serious side effects that only add on to the stress, pain, and frustration that patients already feel due to their condition. Florida marijuana (F.M.):

Hybrid 189

Hybrid Marijuana Sativa Nerve Pain 189

Cannabis Law Report

JULY 7, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. About MyMD Pharmaceuticals, Inc. MyMD is a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms. Eurofins is a global leader in food, environment, and pharmaceutical product testing.

Pharmaceutical 81

Pharmaceutical Data Clinical Trials Research and Development 81

FloridaMarijuana.net

JULY 16, 2018

No need to take pills that could do more harm than good; or deal with painful side effects that pharmaceuticals cause. Patients that are seeking a natural and alternative medicine to the condition they are facing can register for a medical marijuana card by starting here. I felt free from my ailment. Medical records & History.

Marijuana 189

Marijuana Patients Conditions Treatment 189

Cannabis Law Report

DECEMBER 23, 2021

DUBLIN–(BUSINESS WIRE)– “The Pharmaceutical Cannabis Report: 2nd Edition” report has been added to ResearchAndMarkets.com’s offering. In both Europe and the United States, the sales of unapproved cannabis products such as smokable flower and full spectrum oils dwarf those of approved pharmaceuticals.

Pharmaceutical 74

Pharmaceutical Clinical Trials Research and Development Cannabinoids 74

NORML

NOVEMBER 8, 2019

Polling from the American Legion shows that nearly 1 in 4 veterans consume marijuana to alleviate symptoms of a medical or physical condition. Prohibiting VA doctors from recommending cannabis to qualifying patients, while continuing to rely on pharmaceuticals drugs like opioids as a treatment, is both a dangerous and illogical policy.

Access 232

Access Marijuana Treatment Legislation 232

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. About InMed: InMed Pharmaceuticals is a clinical stage pharmaceutical company developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol (CBN) in diseases with high unmet medical need.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

NORML

JUNE 13, 2019

Millions of Americans are legally replacing pharmaceuticals with cannabis and the question of affordability has become critical. Certain conditions require more cannabinoids than others. Are you paying too much for medical marijuana? All of the state programs are independent and in various stages of maturity.

Marijuana 276

Marijuana Dispensary Patients Retail 276

Cannabis Law Report

AUGUST 24, 2021

BALTIMORE–(BUSINESS WIRE)– $MYMD — MyMD Pharmaceuticals, Inc. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc. Patent protects methods of administering MYMD-1 for treating disorders associated with chronic inflammation, with a focus on fibrosis and asthma.

Pharmaceutical 75

Pharmaceutical Clinical Trials Chronic Pain CBD 75

Cannabis Law Report

SEPTEMBER 9, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, will present at the H.C. MYMD-1 is also being developed as a potential therapy for COVID-19-related conditions such as post-COVID-19 syndromes.

Pharmaceutical 74

Pharmaceutical Clinical Trials Chronic Pain Epilepsy 74

FloridaMarijuana.net

JULY 5, 2018

As with all medicinal interventions, strains may affect each person and medical condition differently. Be sure to speak with your medical marijuana physician about their recommendations based on your individual needs and medical conditions. These descriptions are meant as a guide. Super Sour Diesel/Sativa. Sleepiness.

Strains 189

Strains Chronic Pain Indica Hybrid 189

CannaMD

FEBRUARY 19, 2020

Post-traumatic stress disorder (PTSD) is a condition most often associated with military veterans, but it is not confined to wartime experiences. Medical Marijuana: More Effective Than Pharmaceuticals? To date, there is no pharmaceutical product targeted specifically for the treatment of PTSD.

CBD 108

CBD Pharmaceutical Research and Development Conditions 108

Cannabis Law Report

AUGUST 17, 2021

–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. The condition is caused by inherited mutations in either the TSC1 gene or the TSC2 gene. About Marinus Pharmaceuticals. Marinus Pharmaceuticals, Inc. Marinus Pharmaceuticals, Inc. RADNOR, Pa.–(BUSINESS 484-253-6792.

Pharmaceutical 76

Pharmaceutical Clinical Trials Treatment Patients 76

Veriheal

OCTOBER 13, 2020

Ulcerative Colitis is a condition that causes long-lasting inflammation and ulcers (sores) in the innermost lining of the individual’s large intestine and rectum. Crohn’s Disease is also a condition that causes inflammation, but it affects the lining of the digestive tract, which can then spread deeply into the affected tissues. .

Digestion 124

Digestion Treatment Conditions Research and Development 124

FloridaMarijuana.net

OCTOBER 11, 2018

In particular, terpenoids are contained in many herbal plants, and several terpenoids have been shown to be available for pharmaceutical applications. As with all medicinal interventions, terpenes and strains may affect each person and medical condition differently. These descriptions are meant as a guide.

Terpenes 172

Terpenes Strains Medicine Oil 172

Cannabis Life Network

MARCH 5, 2022

Arthritis is one of the most widely seen medical conditions and even though it is mostly experienced by older people, there are better alternatives out there than pharmaceutical pain killers. A typical solution used by many people to ease the pain.

Strains 110

Strains Pharmaceutical Conditions Cannabis 110

FloridaMarijuana.net

AUGUST 9, 2018

This means that often pharmaceutical medications are experimental. When the body is defensive against trauma or illness, this system begins to fail, resulting in physical, mental and/or neurological conditions. Cannabis offers significant therapeutic benefits for a wide range of medical conditions.

Marijuana 190

Marijuana Patients Clinical Trials Treatment 190

Medical Marijuana Program Connection

FEBRUARY 13, 2024

BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc.®

Pharmaceutical 49

Pharmaceutical Therapy Conditions Business 49

Cannabis Law Report

SEPTEMBER 2, 2022

The pharmaceutical industry takes a serious economic hit after states legalize marijuana—with an average market loss of nearly $10 billion for drugmakers per each legalization event—according to a first-of-its-kind study. By expanding access and, thus use, legalization could permit cannabis to compete with conventional pharmaceuticals.

Pharmaceutical 52

Pharmaceutical Legalization Marijuana Data 52

FloridaMarijuana.net

JUNE 19, 2018

When family members are sick or suffering, its natural to seek relief for their conditions and ailments. Sometimes traditional veterinary pharmaceuticals may not always be effective for dogs and cats and the side-effects may interfere with a pet’s quality of life. When a pet is ill, it can feel like a member of the family is suffering.

Pets 186

Pets CBD Tincture Oil 186

CannaMD

AUGUST 4, 2022

As medical marijuana continues to gain acceptance across the United States and beyond, patients are increasingly turning to cannabis-based therapies as a complement or alternative to prescription pharmaceutical drugs.

Patients 141

Patients Therapy Pharmaceutical Marijuana 141

NORML

JANUARY 24, 2019

The bill would also allow Virginia’s licensed pharmaceutical processors to dispense medical cannabis preparations beyond the current definition of “oil” and in doses proven effective for the variety of disease processes for which doctors will recommend these therapies.

Policy 187

Policy Patients Education Legislation 187

MGC Pharma

MARCH 13, 2018

MXC’s fourth division: MGC Nutraceuticals MGC Pharmaceuticals will be taking its first step into the world of nutraceuticals with the creation of our new brand, MGC Nutraceuticals. MGC Nutraceuticals will allow us to create more dynamic products that, unlike MGC Pharma products, don’t require a prescription, and can be sold anywhere, anytime.

Pharmaceutical 100

Pharmaceutical Conditions CBD eCommerce 100

Project CBD

MARCH 8, 2019

Immediately in response, the FDA announced that CBD is considered a “drug” and is thus subject to pharmaceutical regulations. His forthcoming articles for projectcbd.org will contain practical information on using cannabis to treat medical conditions in pets.

Pets 218

Pets Legalization Hemp Extraction 218

FloridaMarijuana.net

OCTOBER 5, 2018

In particular, terpenoids are contained in many herbal plants, and several terpenoids have been shown to be available for pharmaceutical applications. Patients should speak with their certified medical marijuana physician to determine which strains and methods of consumption are most appropriate for their medical conditions.

Terpenes 181

Terpenes Strains Oil Medicine 181

FloridaMarijuana.net

AUGUST 13, 2018

Florida medical marijuana doctors are recommending medical marijuana for anxiety, depression and many other mental health conditions. Anxiety is one aspect of a broader condition- anxiety disorder. Pharmaceuticals come with side effects, though, and may vary from person-to-person. Medications can be used along with therapy.

Marijuana 145

Marijuana Patients Clinical Trials Conditions 145

FloridaMarijuana.net

APRIL 30, 2019

After ceasing prescribed pharmaceutical use, I introduced Ggr into my wellness routine in addition to incorporating a CBD product and other Trulieve THC products (indica for nighttime use; sativa to add variety). The physical side effects from pharmaceuticals can include nausea, headache, heartburn, diarrhea and constipation.

Chronic Pain 20

Chronic Pain Nerve Pain Hybrid Pharmaceutical 20

PrestoDoctor

DECEMBER 12, 2023

Additionally, cannabis has shown promise in easing symptoms of chronic conditions such as arthritis, insomnia, and anxiety. Additionally, using cannabis for medical conditions does not mean THC must be consumed. CBD also plays an important role in management of conditions without the psychoactive high.

Medicine 98

Medicine Chronic Pain Consumption Pharmaceutical 98

MGC Pharma

FEBRUARY 22, 2018

of respondents who received Medical Cannabis treatment reported improvement in their condition and significant reductions to pain levels. An increasing number of older people are seeking the treatment for conditions such as inflammatory arthritis, autoimmune disease and chronic pain.

Research and Development 100

Research and Development Pharmaceutical Chronic Pain Treatment 100

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

Medical marijuana laws have changed dramatically across the country in recent years, and now cannabis pharmaceuticals appear to be the next big leap forward in cannabis law reform. Children who suffer from these conditions generally experience social and developmental delays due to constant seizures. What Does Epidiolex Treat?

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. Zambon is a multinational pharmaceutical company that focuses on innovation and development with the aim to improve patients’ lives. The market for medical cannabis in Germany.

Access 105

Access Research and Development Pharmaceutical Therapy 105